col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


44 Results       Page 1

 [1] 
Wiley: Hematological Oncology
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―25 Erratum to reply to “successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients-A Czech multicenter experience”: A case series of SARS-CoV-2 Omicron infection and aggressive lymphoma in the Sotrovimab era
2 [GO] 2024―Mar―01 Mortality associated to hematological malignancies across pandemic waves in 2020: A nationwide analysis of multiple causes of death in Italy Enrico Grande, Francesco Grippo, Claudio Barbiellini Amidei, Ugo Fedeli, Alberto Tosetto
3 [GO] 2023―Dec―05 Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the epicovideha registry Pellegrino Musto, Jon Salmanton-García, Nicola Sgherza, Rui Bergantim, Francesca Farina, Andreas Glenthøj, et al. (+81)
4 [GO] 2023―Jul―15 Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection Zeno Pasquini, Alice Toschi, Beatrice Casadei, Cinzia Pellegrini, Alessandra D’Abramo, Serena Vita, et al. (+11)
5 [GO] 2023―Jul―13 The course of patients with hairy cell leukemia during the omicron surge of the Covid-19 pandemic Tamar Tadmor, Guy Melamed, Tal Patalon, Hilel Alapi, Lior Rokach
6 [GO] 2023―Jun―09 LOW MORTALITY FROM COVID-19 IN PATIENTS WITH B CELL LYMPHOMA AFTER BISPECIFIC CD3 X CD20 THERAPY E. R. Kyvsgaard, C. Riley, M. R. Clausen, L. D. Heftdal, C. Niemann, K. Grønbæk, et al. (+2)
7 [GO] 2023―Jun―09 THE INCIDENCE OF INTERSTITIAL PNEUMONIA IN NEWLY TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS DURING THE COVID-19 PANDEMIC: A SINGLE-CENTER, RETROSPECTIVE ANALYSIS OF CONSECUTIVE CASES J. Guo, Y. Liang, C. Wang, L. Wang
8 [GO] 2023―Jun―09 ASSOCIATION OF COVID-19 PANDEMIC WITH INDOLENT LYMPHOMA CARE DELIVERY AND OUTCOMES IN ONTARIO, CANADA: A POPULATION-BASED ANALYSIS I. Y. Gong, A. Prica, Z. Ante, A. Calzavara, M. C. Cheung, M. Crump
9 [GO] 2023―Jun―09 FACTORS INFLUENCING SURVIVAL AND PROLONGED VIRAL REPLICATION IN PATIENTS WITH LYMPHOMA AND COVID-19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP A. Cabero-Martínez, M. Bastos-Oreiro, A. López-García, M. Baile, M. Franch, M. J. Llacer-Ferrandis, et al. (+33)
10 [GO] 2023―Jun―09 Impact of COVID-19 infection on bispecific antibodies treatment in patients diagnosed with B-cell lymphoproliferative disorders A. Serna, J. Iraola-Truchuelo, M. Jiménez, A. Cabirta, A. Albasanz, I. Ruiz-Camps, et al. (+11)
11 [GO] 2023―Jun―09 Predicting COVID-19 infection risk in lymphoma by immune monitoring R. Wijaya, N. Campbell, M. Johnson, B. Stuart, A. Kelly, N. Tipler, et al. (+12)
12 [GO] 2023―Jun―09 TIXAGEVIMAB-CILGAVIMAB THERAPY IN THE PREVENTION OF SARS-COV2 INFECTION IN NON HODGKIN-B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE L. Pezzullo, V. Giudice, M. D'Addona, M. T. Buonanno, D. De Novellis, I. Ferrara, et al. (+7)
13 [GO] 2023―Jun―09 IDENTIFYING FACTORS THAT AFFECT BARRIERS TO LYMPHOMA TREATMENT DURING THE COVID - 19 PANDEMIC S. E. Kalloger, A. R. Watson, C. Bates, L. E. Warwick, N. Bolanos
14 [GO] 2023―May―13 Mortality in COVID-19 hospitalizations with underlying hematologic malignancies in the United States Aditi Sharma, Abhinav Deol, Vijendra Singh
15 [GO] 2023―Apr―14 Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown Maria Kislova, Andrei Petrenko, Elena A. Dmitrieva, Alexander Milenkin, Konstantin E. Nikitin, Vadim V. Ptushkin, et al. (+2)
16 [GO] 2023―Feb―14 COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation Lorenzo Masina, Nicola Bianchetti, Angela Passi, Chiara Bottelli, Samuele Bagnasco, Angelica Spolzino, et al. (+8)
17 [GO] 2022―Dec―31 COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients Giovanni Del Poeta, Roberta Laureana, Riccardo Bomben, Francesca Maria Rossi, Federico Pozzo, Eva Zaina, et al. (+13)
18 [GO] 2022―Dec―28 Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion Metafuni Elisabetta, Antonella Cingolani, Massimo Fantoni, Patrizia Chiusolo, Sabrina Giammarco, Federica Sorà, et al. (+14)
19 [GO] 2022―Oct―20 SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort Michele Merli, Isacco Ferrarini, Francesco Merli, Alessandro Busca, Roberto Mina, Brunangelo Falini, et al. (+34)
20 [GO] 2022―Oct―17 Management of patients with lymphoma and COVID-19: NARRATIVE REVIEW AND EVIDENCE-BASED PRACTICAL RECOMMENDATIONS Francesco Passamonti, Emanuele Nicastri, Alice Di Rocco, Attilio Guarini, Adalberto Ibatici, Stefano Luminari, et al. (+2)
21 [GO] 2022―Oct―14 Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A SYSTEMATIC REVIEW AND META-ANALYSIS Elena Carrara, Elisa Razzaboni, Anna Maria Azzini, Maria Elena De Rui, Mariana Nunes Pinho Guedes, Anna Gorska, et al. (+11)
22 [GO] 2022―Sep―26 Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia Fiorcari S, Atene CG, Maffei R, Mesini N, Debbia G, Colasante C, et al. (+7)
23 [GO] 2022―Sep―26 Reply to “Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience “: A CASE SERIES OF SARS-COV-2 OMICRON INFECTION AND AGGRESSIVE LYMPHOMA IN THE SOTROVIMAB ERA Cassin R, Rampi N, Fidanza C, Muscatello A, Mariani B, Noto A, et al. (+2)
24 [GO] 2022―Aug―07 High mortality in fully vaccinated hematologic patients treated with anti-CD20 antibodies during the “Omicron wave” of COVID-19 pandemic Chiara Cattaneo, Lorenzo Masina, Chiara Pagani, Valeria Cancelli, Rosa Daffini, Alessandra Tucci, Giuseppe Rossi
25 [GO] 2022―Aug―06 LACK OF EFFICACY OF CONVALESCENT PLASMA IN COVID-19 PATIENTS WITH CONCOMITANT HEMATOLOGICAL MALIGNANCIES AN ITALIAN RETROSPECTIVE STUDY Lanza F, Monaco F, Ciceri F, Cairoli R, Sacchi MV, Guidetti A, et al. (+16)
26 [GO] 2022―Jul―20 Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies a report from the ITA-HEMA-COV Patrizia Zappasodi, Chiara Cattaneo, Virginia Ferretti, Roberto Mina, Andrés José María Ferreri, Francesco Merli, et al. (+48)
27 [GO] 2022―Jul―19 Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients L. Pettine, M. Bortolotti, B. Fattizzo, M. Da Vià, D. Consonni, A. Pompa, et al. (+2)
28 [GO] 2022―Mar―19 Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia Stefano Molica, Constantine Tam, Aaron Polliack
29 [GO] 2022―Feb―04 Successful Early Use of Anti-SARS-CoV-2 Monoclonal Neutralizing Antibodies in SARS-CoV-2 Infected Hematological Patients - A Czech Multicenter Experience Barbora Weinbergerová, Ivo Demel, Benjamin Víšek, Jan Válka, Martin Čerňan, Pavel Jindra, et al. (+10)
30 [GO] 2022―Jan―25 SUBCUTANEOUS IMMUNOGLOBULINS IN CHRONIC LYMPHOCYTIC LEUKAEMIA WITH SECONDARY ANTIBODY DEFICIENCY. A MONOCENTRIC EXPERIENCE DURING COVID-19 PANDEMICS Idanna Innocenti, Annamaria Tomasso, Giulia Benintende, Francesco Autore, Alberto Fresa, Florenzia Vuono, et al. (+6)
31 [GO] 2021―Dec―15 SARS-CoV-2 Vaccine Response in CAR T-cell Therapy Recipients: A Systematic Review and Preliminary Observations Muhammad Abbas Abid, Muhammad Bilal Abid
32 [GO] 2021―Aug―31 COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients Giovanni Del Poeta, Riccardo Bomben, Jerry Polesel, Francesca Maria Rossi, Federico Pozzo, Eva Zaina, et al. (+11)
33 [GO] 2021―Aug―16 Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients Barbora Weinbergerova, Jiri Mayer, Tomas Kabut, Stepan Hrabovsky, Jirina Prochazkova, Zdenek Kral, et al. (+7)
34 [GO] 2021―Aug―12 OUTCOMES OF PATIENTS WITH LYMPHOMA AND COVID-19: AN OBSERVATIONAL COHORT STUDY FROM GELTAMO SPANISH GROUP A. Martín García-Sancho, M. Izuzquiza, M. Bastos-Oreiro, M. Baile, S. Nistal, M. Cortés, et al. (+27)
35 [GO] 2021―Jul―14 Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, Giulia Quaresmini, Lydia Scarfò, Francesca Romana Mauro, et al. (+38)
36 [GO] 2021―Jun―17 IMPAIRED HUMORAL RESPONSE IN LYMPHOMA PATIENTS SURVIVING THE ACUTE PHASE OF COVID-19 C. Cattaneo, V. Cancelli, C. Pagani, A. Ogna, A. Tucci, G. Rossi, et al. (+6)
37 [GO] 2021―Jun―17 MULTICENTER RETROSPECTIVE ANALYSIS OF RISK FACTORS FOR MORTALITY OF COVID-19 INFECTION IN PATIENTS WITH LYMPHOMA J. Kořen, K. Steinerová, A. Janíková, D. Belada, B. Hájková, M. Krčméryová, et al. (+8)
38 [GO] 2021―Jun―17 A NON-INTERVENTIONAL STUDY OF OBINUTUZUMAB IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (URBAN): IMPACT OF COVID-19 PANDEMIC ON ENROLLMENT AND SAFETY A ., P. L . Zinzani, L . Arcaini, G . Gritti, C . Patti, E . Pennese, et al. (+4)
39 [GO] 2021―Jun―17 IMPACT OF THE COVID-19 PANDEMIC ON THE DIAGNOSIS OF MATURE LYMPHOID NEOPLASMS IN BELGIUM: RESULTS FROM THE BELGIAN CANCER REGISTRY H. Antoine-Poirel, F. Calay, T. Tambuyzer, P. Denolf, L. Van Eycken
40 [GO] 2021―Jun―17 IMPACT OF DISEASE TREATMENT ON THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH COVID-19: A MULTICENTER STUDY ON BEHALF OF GELLC A. Muntañola, F. Mirás, J. A. Hernández-Rivas, M. Baile, S. Osorio, Ma J. Terol, et al. (+49)
41 [GO] 2021―Jun―17 SARS-COV-2 INFECTION IN 50 PATIENTS WITH PRIMARY CNS LYMPHOMA: PRESENTATION, EFFECTS ON TUMOR TREATMENT AND OUTCOME IN A SERIES OF THE INTERNATIONAL PCNSL COLLABORATIVE GROUP A. J. M. Ferreri, S. Steffanoni, T. Calimeri, A. Laurenge, C. P. Fox, C. Soussain, et al. (+12)
42 [GO] 2021―Jun―17 SEROLOGICAL RESPONSES AFTER SARS-COV-2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY S.H. Lim, N. Campbell, D. Joseph-Pietras, M. Johnson, C. Mundy, H. Coleman, et al. (+16)
43 [GO] 2021―May―06 Intrahospital COVID-19 infection outbreak management: Keep calm and carry on Anna M. Frustaci, Maria L. Pioltelli, Emanuele Ravano, Federica Di Ruscio, Daniela A. Campisi, Massimo Puoti, Roberto Cairoli
44 [GO] 2021―May―06 Seroconversion and kinetic of anti SARS-COV-2 antibodies in 25 patients with hematological malignancies WHO recovered from SARS-COV-2 infection Anna Candoni, Umberto Pizzano, Martina Fabris, Francesco Curcio, Renato Fanin
 [1] 

44 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec